Accelerating Cell Therapy Development: Challenges and Opportunities

Cell therapies offer unprecedented potential to treat a wide range of diseases. This session will explore strategies to accelerate the development and approval of these life-saving therapies by leveraging innovative regulatory pathways.

Key topics will include:

Navigating regulatory landscapes: Discussions will delve into the complexities of navigating regulatory requirements including reviewing case studies

Leveraging accelerated pathways: We will explore the potential of utilizing regulatory pathways such as Fast Track, and RMAT Designation, and Priority Review to expedite the development and review of promising cell therapies.

Addressing emerging regulatory challenges: The rapid evolution of cell therapy technologies presents unique regulatory challenges. We will discuss emerging regulatory considerations, such as those related to cell sourcing, and manufacturing processes.

This session will provide overview of cell therapy drug development for the early to mid career professionals but also discuss best practices, and identify innovative approaches to accelerate the development and of life-saving cell therapies.